title: Medicolegal issues surrounding Depo-Provera easily overcome.
mesh_terms: D000569:Americas; D003257:Consumer Product Safety; D003267:Contraception; D003268:Contraception Behavior; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003695:Delivery of Health Care; D019049:Developed Countries; D004194:Disease; D011307:Drug Prescriptions; D005193:Family Planning Services; D006262:Health; D006282:Health Personnel; D006285:Health Planning; D006470:Hemorrhage; D007258:Informed Consent; D007878:Legislation as Topic; D017258:Medroxyprogesterone Acetate; D009656:North America; D009934:Organization and Administration; D010820:Physicians; D012816:Signs and Symptoms; D014481:United States
chemical_list: D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate
keywords: Americas; Bleeding; Contraception; Contraceptive Agents, Female--legal aspects; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--legal aspects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--legal aspects; Contraceptive Agents--side effects; Contraceptive Usage; Delivery Of Health Care; Depo-provera--legal aspects; Depo-provera--side effects; Developed Countries; Diseases; Distributional Activities; Family Planning; Health; Health Personnel; Informed Consent; Legislation; Medroxyprogesterone Acetate--legal aspects; Medroxyprogesterone Acetate--side effects; North America; Northern America; Organization And Administration; Physicians; Prescriptions; Product Approval; Program Activities; Programs; Signs And Symptoms; United States